Advertisement
Advertisement

CURX

C

Curanex Pharmaceuticals Inc Common Stock

0.32
USD
Sponsored
+0.01
+2.34%
May 08, 15:53 UTC -4
Closed
exchange

After-Market

0.32

0.00
-0.31%

Curanex Pharmaceuticals Inc Common Stock Profile

About

Curanex Pharmaceuticals Inc. is a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases. Its lead candidate includes Phyto-N. Curanex Pharmaceuticals Inc. is headquartered in Jericho, New York.

Info & Links

CEO

Jun Liu

Headquarters

2 JERICHO PLAZA, SUITE 101B
JERICHO, NY 11753, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.curanexpharma.com

Auditor

Kreit & Chiu CPA LLP

Share holders

--

Employees

--

Curanex Pharmaceuticals Inc Common Stock Statistics

Valuation Measures

Market Capitalization2

9.13M

Enterprise Value

4.16M

Enterprise Value/EBITDA(ttm)

-4.34

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.19

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-49.10%

Return on Invested Capital(ttm)

-53.82%

Return on Assets(ttm)

-47.22%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-959.30K

Net Income Available to Common(ttm)

-4.23M

Diluted EPS(ttm)

-0.17

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

28.36M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

4.97M

Total Cash Per Share(mrq)

0.18

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

81.93%

Quick Ratio(mrq)

81.94%

Book Value Per Share(mrq)

0.40

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.41

Free Cash Flow(ytd)

-10.48M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement